Rwanda: Lenacapavir Offers Hope Against HIV, Now the World Must Act
12 Articles
12 Articles
Call for new HIV\AIDS prevention jab to be accessible to all
Call for new HIV\AIDS prevention jab to be accessible to all Ntandoyenkosi… Sat, 07/19/2025 - 14:00 SAO PAULO, BRAZIL - A new HIV prevention drug, lenacapavir, is being called a major breakthrough.The WHO has released new guidelines for the twice-yearly injection, said to be 100% effective.Dr Antonio Flores from Doctors Without Borders says this jab provides long term prevention with high effectiveness.
VivaBem, UOL's new health and well-being channel with reliable and scientifically based information, tested tips, and expert guidance
Key Clinical Updates from June 2025
In June, the FDA approved Gilead’s twice-yearly shot for HIV prevention and Nuvation Bio's ROS1 inhibitor for non-small cell lung cancer. Meanwhile, Arvinas and Pfizer have filed for approval for their estrogen receptor PROTAC, vepdegestrant, and Monte Rosa Therapeutics plans to start a Ph. 1 trial of a NEK7 degrader for inflammatory diseases. Novo Nordisk is planning Ph. 3 trials of its amylin analog/GLP-1 agonist combination in weight loss, an…
Tamar Braxton Is Raising Awareness About The Power Of PrEP Under Her New Partnership With Gilead Sciences
Source: Photo Credit: Getty Images for ESSENCE Tamar Braxton wants Black women to put their sexual health first. The Grammy-nominated singer, chef, and actress has announced a new brand partnership with Gilead Sciences, the pharmaceutical giant behind PrEP (pre-exposure prophylaxis), a medicine for people at risk of contracting HIV. Braxton, who revealed she was a proud user of PrEP in March, announced the exciting partnership at ESSENCE Festiva…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium